Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Vasculitis Guidelines in Focus, Part 5: Takayasu Arteritis

Michael Putman, MD  |  October 11, 2021

Andy Abril, MD, a lead author of the ACR/VF guideline for Takayasu arteritis (TAK), discusses the recommendations for TAK.

Filed under:Clinical Criteria/GuidelinesConditionsVasculitis Tagged with:guidelineTakayasu arteritis (TAK)VasculitisVasculitis Foundation

Lively, Practical Training at Advocacy 101

Leslie Mertz, PhD  |  October 11, 2021

Amid spirited discussions on drug pricing and insurance challenges, participants got hands-on experience advocating for current bills regulating prior authorization and pharmacy benefit managers.

Filed under:Legislation & Advocacy Tagged with:Advocacy 101Advocates for ArthritisAmanda SchnellDeepika SinghLegislation & AdvocacySamuel Gagne

The Latest Psoriatic Arthritis Management Insights

Jason Liebowitz, MD, FACR  |  October 11, 2021

An overview of the research to date and the ways in which such evidence can be used to guide the treatment of patients was presented at the 2019 ACR/ARP Annual Meeting in a session titled Optimizing Outcomes in Psoriatic Arthritis: A Domain-Based Strategy. In the years since this presentation, additional research has helped supply greater…

Filed under:ConditionsPsoriatic Arthritis Tagged with:Psoriatic Arthritis

Dusty Trades: Inorganic Dust Exposure During Military Service May Be an Occupational Risk Factor for RA

Lara C. Pullen, PhD  |  October 7, 2021

Mounting evidence indicates that exposure to inorganic dust is a risk factor for the development of autoimmune diseases. According to a recent study, dust exposure during military service in dusty environments represents an occupational and environmental risk and was associated with a 10% increased risk of developing RA.

Filed under:ConditionsRheumatoid Arthritis Tagged with:ACR Open Rheumatologyexposureinorganic dust exposurejobMilitaryRheumatoid Arthritis (RA)Risk Factors

Vasculitis Guidelines in Focus, Part 4: Polyarteritis Nodosa

Michael Putman, MD  |  September 22, 2021

Jason Springer, MD, MS, served as one of the lead authors of the ACR/VF guidelines for polyarteritis nodosa (PAN), and talks about the recommendations specific to PAN here.

Filed under:Clinical Criteria/GuidelinesConditionsVasculitis Tagged with:Guidelinespolyarteritis nodosaVasculitisVasculitis Foundation

Tocilizumab Effective for Early SSc-Associated Interstitial Lung Disease

Lara C. Pullen, PhD  |  September 22, 2021

Treatment with tocilizimab preserved lung function in patients with systemic sclerosis (SSc) and interstitial lung disease (ILD) regardless of a patient’s level of lung involvement, according to a recent study.

Filed under:Conditions Tagged with:interstitial lung disease (ILD)systemic sclerosis (SSc)systemic sclerosis-associated ILDtocilizumab

Inspired by Healthcare Disparities to Advocate for Change

Leslie Mertz, PhD  |  September 21, 2021

Seeing the challenges her rural patients faced in accessing specialty care, Amanda Schnell, MD, was inspired to make advocacy an integral part of her work at the University of Alabama at Birmingham.

Filed under:Legislation & AdvocacyProfiles Tagged with:AdvocacyAmanda SchnellGovernment Affairs Committee (GAC)healthcare disparitiesrural areas

Vasculitis Guidelines in Focus, Part 3: EGPA

Michael Putman, MD  |  September 14, 2021

In this third article in the series, we talk with Philip Seo, MD, MHS, about eosinophilic granulomatosis with polyangiitis (EGPA).

Filed under:Clinical Criteria/GuidelinesConditionsVasculitis Tagged with:AAV FocusRheumEGPAeosinophilic granulomatosis with polyangiitis (EGPA)guidelineVasculitis

Summer 2021’s Awards, Appointments & Announcements in Rheumatology

Kelly April Tyrrell & Gretchen Henkel  |  September 14, 2021

Marian Hannan Celebrated after 10 Years as AC&R Editor-in-Chief By Kelly April Tyrrell This summer, the 10-year tenure of Marian Hannan, MPH, DSc, as editor in chief of Arthritis Care & Research (AC&R), has come to an end. Kelli Allen, PhD, assumed the post on July 1. “Marian has done a fantastic job over the…

Filed under:AwardsProfiles Tagged with:Dr. John J. O’SheaDr. Marian HannanDr. Tuhina Neogi

Using Different Fibromyalgia Criteria Affects Prevalence Estimates

Deborah Levenson  |  September 14, 2021

A recent paper illustrates how using different fibromyalgia criteria affects reports of its prevalence.1 Writing in Arthritis Care & Research, researchers found the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks–American Pain Society Pain Taxonomy (AAPT) criteria caused far more people to be categorized as having fibromyalgia than criteria put forth by…

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:Classification CriteriaFibromyalgia

  • « Previous Page
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences